NYSE:INSPMedical Equipment
Inspire Medical’s Q4 Beat And Inspire V Adoption Reframe Valuation Debate
Inspire Medical Systems (NYSE:INSP) reported strong Q4 results, highlighting solid revenue performance.
The company raised its full year guidance, which it describes as leading among its peer group.
Management reported successful early commercial adoption of its next generation Inspire V device.
For investors tracking NYSE:INSP, this update comes after a difficult stretch for the share price, with the stock at $62.99 and showing a 31.7% decline year to date and a 65.6% decline over the past...